{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:29Z","timestamp":1791910409953,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,27]],"date-time":"2027-09-27T00:00:00Z","timestamp":1822003200000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00045"],"award-info":[{"award-number":["75N93021C00045"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.vaccine.2026.129189","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:52:44Z","timestamp":1790509964000},"page":"129189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sex differences in vaccine-induced neuraminidase cross-recognition impact H5N1 dissemination to the lower respiratory tract in mice"],"prefix":"10.1016","volume":"93","author":[{"given":"Sabal","family":"Chaulagain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maclaine A.","family":"Parish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattya Narayan","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany A.","family":"Seibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianle","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosette","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pekosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabra L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129189_bb0005","series-title":"The influenza viruses","first-page":"175","article-title":"Neuraminidase: enzyme and antigen","author":"Colman","year":"1989"},{"issue":"22","key":"10.1016\/j.vaccine.2026.129189_bb0010","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","article-title":"Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium","volume":"78","author":"Matrosovich","year":"2004","journal-title":"J Virol"},{"issue":"25","key":"10.1016\/j.vaccine.2026.129189_bb0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"New England J Med"},{"issue":"5937","key":"10.1016\/j.vaccine.2026.129189_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 a (H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"science"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129189_bb0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3201\/eid3007.240508","article-title":"Highly pathogenic avian influenza A (H5N1) clade 2.3. 4.4 b virus infection in domestic dairy cattle and cats, United States, 2024","volume":"30","author":"Burrough","year":"2024","journal-title":"Emerg Infect Dis"},{"issue":"8034","key":"10.1016\/j.vaccine.2026.129189_bb0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","article-title":"Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle","volume":"634","author":"Caserta","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.129189_bb0035","doi-asserted-by":"crossref","unstructured":"Werner AP, Schneider CG, Akin EH, Hayes J, Fenstermacher KZ, Rothman RE, et al. Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination. mBio 2025;16(12):e02145\u201325.","DOI":"10.1128\/mbio.02145-25"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129189_bb0040","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/j.vaccine.2012.01.090","article-title":"The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets","volume":"30","author":"Chen","year":"2012","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2026.129189_bb0045","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half-vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129189_bb0050","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1073\/pnas.1321060111","article-title":"Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination","volume":"111","author":"Furman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"49","key":"10.1016\/j.vaccine.2026.129189_bb0055","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1073\/pnas.1805268115","article-title":"Biological sex affects vaccine efficacy and protection against influenza in mice","volume":"115","author":"Fink","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.129189_bb0060","doi-asserted-by":"crossref","unstructured":"Ursin Rebecca L, Dhakal S, Liu H, Jayaraman S, Park H-S, Powell Harrison R, et al. Greater breadth of vaccine-induced immunity in females than males is mediated by increased antibody diversity in germinal Center B cells. mBio 2022;13(4):e01839\u201322.","DOI":"10.1128\/mbio.01839-22"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129189_bb0065","doi-asserted-by":"crossref","first-page":"ofae222","DOI":"10.1093\/ofid\/ofae222","article-title":"Sex differences in the immunogenicity and efficacy of seasonal influenza vaccines: a meta-analysis of randomized controlled trials","volume":"11","author":"Tadount","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129189_bb0070","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3201\/eid3106.241796","article-title":"Investigation of influenza a(H5N1) virus neutralization by quadrivalent seasonal vaccines, United Kingdom, 2021-2024","volume":"31","author":"Stevenson-Leggett","year":"2025","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129189_bb0075","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129189_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02332-17","article-title":"NAction! How can neuraminidase-based immunity contribute to better influenza virus vaccines?","volume":"9","author":"Krammer","year":"2018","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0085","doi-asserted-by":"crossref","first-page":"2654278","DOI":"10.1080\/22221751.2026.2654278","article-title":"Cross-protection against highly pathogenic avian influenza H5N1 virus from seasonal influenza vaccines: a systematic review and meta-analysis of ferret studies","volume":"15","author":"Tseng","year":"2026","journal-title":"Emerging Microbes Infect"},{"key":"10.1016\/j.vaccine.2026.129189_bb0090","doi-asserted-by":"crossref","unstructured":"Singh G, Bhavsar D, Hermann E, Gleason C, Singh Sandhu H, Singh P, et al. Population immunity to clade 2.3.4.4b H5N1 is dominated by anti-neuraminidase antibodies. mBio 2026;0(0):e00445\u201326.","DOI":"10.64898\/2026.02.10.26346014"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-70036-8","article-title":"Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses","volume":"17","author":"Moriyama","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.129189_bb0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-019-0124-6","article-title":"Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females","volume":"4","author":"Potluri","year":"2019","journal-title":"NPJ Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00326-24","article-title":"Estradiol mediates greater germinal center responses to influenza vaccination in female than male mice","volume":"15","author":"Dhakal","year":"2024","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129189_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/v15020482","article-title":"How Estrogen, testosterone, and sex differences influence serum immunoglobulin isotype patterns in mice and humans","volume":"15","author":"Surman","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129189_bb0120","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"Rockman","year":"2013","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2026.129189_bb0125","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza a viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0130","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41467-023-37162-z","article-title":"Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies","volume":"14","author":"Myers","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129189_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150700","article-title":"Influenza vaccine manufacturing: effect of inactivation, splitting and site of manufacturing. Comparison of influenza vaccine production processes","volume":"11","author":"Kon","year":"2016","journal-title":"PLoS One."},{"issue":"9","key":"10.1016\/j.vaccine.2026.129189_bb0140","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1182\/blood-2015-09-625343","article-title":"Influence of immunoglobulin isotype on therapeutic antibody function","volume":"127","author":"Beers","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129189_bb0145","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00323-20","article-title":"Murine cross-reactive nonneutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice","volume":"94","author":"Shibuya","year":"2020","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129189_bb0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129189_bb0155","article-title":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza a virus infection","volume":"6","author":"O\u2019Brien","year":"2011","journal-title":"PloS One"},{"issue":"20","key":"10.1016\/j.vaccine.2026.129189_bb0160","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00969-18","article-title":"Complement C3 plays a key role in inducing humoral and cellular immune responses to influenza virus strain-specific hemagglutinin-based or cross-protective M2 extracellular domain-based vaccination","volume":"92","author":"Kim","year":"2018","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0165","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection","volume":"8","author":"Kopf","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129189_bb0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/iai.30.2.362-369.1980","article-title":"Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine","volume":"30","author":"Quinnan","year":"1980","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2026.129189_bb0175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.4161\/hv.21025","article-title":"Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals","volume":"8","author":"Co","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0180","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0185","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-017-00928-3","article-title":"Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza a virus in mice","volume":"8","author":"He","year":"2017","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129189_bb0190","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/jvi.2.4.281-288.1968","article-title":"Antiviral activity of antiserum specific for an influenza virus neuraminidase","volume":"2","author":"Kilbourne","year":"1968","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0200","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1432-1033.1997.00332.x","article-title":"Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase","volume":"247","author":"Martinet","year":"1997","journal-title":"Eur J Biochem"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0205","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01584-17","article-title":"Antibodies directed toward neuraminidase N1 control disease in a mouse model of influenza","volume":"92","author":"Job","year":"2018","journal-title":"J Virol"},{"issue":"6464","key":"10.1016\/j.vaccine.2026.129189_bb0210","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.129189_bb0215","doi-asserted-by":"crossref","unstructured":"Job E, Ysenbaert T, Smet A, Van Hecke A, Meuris L, Kleanthous H, et al. Fc\u03b3 receptors contribute to the antiviral properties of influenza virus neuraminidase-specific antibodies. MBio 2019;10(5):10.1128\/mbio.01667-19.","DOI":"10.1128\/mBio.01667-19"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129189_bb0220","first-page":"91","article-title":"Immunity to influenza in ferrets: VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines","volume":"72","author":"McLaren","year":"1974","journal-title":"Epidemiol Infect"},{"issue":"6313","key":"10.1016\/j.vaccine.2026.129189_bb0225","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1126\/science.aag1322","article-title":"Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting","volume":"354","author":"Gostic","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.129189_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105153","article-title":"A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein","volume":"104","author":"Bliss","year":"2024","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129189_bb0235","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza a virus nucleoprotein is a major target antigen for cross-reactive anti-influenza a virus cytotoxic T lymphocytes","volume":"82","author":"Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2026.129189_bb0240","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza a subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129189_bb0245","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","article-title":"Virus-specific T cells as correlate of (cross-)protective immunity against influenza","volume":"33","author":"Altenburg","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129189_bb0250","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.145.3.557","article-title":"Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza a viruses","volume":"145","author":"Effros","year":"1977","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129189_bb0255","first-page":"417","article-title":"Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo","volume":"58","author":"Taylor","year":"1986","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129189_bb0260","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2026.129189_bb0265","doi-asserted-by":"crossref","unstructured":"Seibert BA, Parish MA, Talukdar SN, Zhang T, Liu JA, Chaulagain S, et al. Trimester-dependent vertical transmission of H5N1 influenza virus through placental and mammary routes impairs offspring development. bioRxiv 2025:2025.07. 07.663583.","DOI":"10.1101\/2025.07.07.663583"},{"key":"10.1016\/j.vaccine.2026.129189_bb0270","doi-asserted-by":"crossref","unstructured":"Canaday LM, Resnick JD, Liu H, Powell H, McCoy AM, Nguyen D, et al. HA and M2 sequences alter the replication of 2013-16 H1 live attenuated influenza vaccine infection in human nasal epithelial cell cultures. Vaccine 2022;40(32):4544\u201353.","DOI":"10.1016\/j.vaccine.2022.05.088"},{"issue":"24","key":"10.1016\/j.vaccine.2026.129189_bb0275","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.vaccine.2021.04.057","article-title":"Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures","volume":"39","author":"Powell","year":"2021","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2026.129189_bb0280","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00797-19","article-title":"Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs","volume":"93","author":"Dhakal","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.129189_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127409","article-title":"COVID-19 vaccine (NVX-CoV2373 and NVX-CoV2540) doses and virus strain match impact sex- and age-specific immunity and protection in mice","volume":"61","author":"Chaulagain","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129189_bb0290","series-title":"A simple method of estimating fifty per cent endpoints","author":"Reed","year":"1938"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:25:02Z","timestamp":1791908702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":58,"alternative-id":["S0264410X26009989"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129189","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in vaccine-induced neuraminidase cross-recognition impact H5N1 dissemination to the lower respiratory tract in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129189"}}